USPTO serial 79285954
BIOHALE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 26, 2021
- Examiner
- O'BRIEN, ELIZABETH A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BIOHALE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and organic excipients for use in the manufacture of pharmaceutical preparations; chemical and organic compositions for use in the manufacture of pharmaceuticals; enzymes in the nature of saccharides for use in the pharmaceutical industry; carbonic hydrates for pharmaceutical purposes; amino acids for laboratory or research use; amino acids for industrial purposes | ACTIVE | — |
| 005 | Pharmaceuticals for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for pharmaceutical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for medical purposes for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; hyaluronic acids for pharmaceutical purposes; hyaluronic acids for medical purposes; amino acids for pharmaceutical purposes; amino acids for medical purposes; lactose for pharmaceutical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FrieslandCampina Nederland B.V.
- Other trademarks owned by FrieslandCampina Nederland B.V.
- Other trademarks owned by FrieslandCampina Nederland B.V.
- Other trademarks owned by DFE Pharma GmbH & Co. KG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named BIOHALE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 26, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 13, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 30, 2024 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 23, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 30, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 30, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 26, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 26, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 10, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 10, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 21, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 1, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 1, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 29, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 17, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 16, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 22, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 21, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |